praziquantel has been researched along with Liver Diseases, Parasitic in 69 studies
azinox: Russian drug
Liver Diseases, Parasitic: Liver diseases caused by infections with PARASITES, such as tapeworms (CESTODA) and flukes (TREMATODA).
Excerpt | Relevance | Reference |
---|---|---|
"Repeated praziquantel treatment for schistosomiasis is an effective method to reduce disease burden." | 7.96 | Change in schistosomiasis-related liver disease with repeated praziquantel treatment in school children in rural Zambia. ( McAdam, D; Paul, E; Strahan, R, 2020) |
"To investigate trends in the efficacy of praziquantel (PZQ) suggestive of the emergence of drug resistance against Schistosoma mansoni infection after 12." | 7.75 | Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya. ( Black, CL; Colley, DG; Evan Secor, W; Karanja, DM; Mwinzi, PN; Steinauer, ML, 2009) |
"The effect of treatment with praziquantel (PZQ) on the tegument of adult Schistosoma mansoni worms and on liver egg-granulomas has been examined in mice infected with PZQ-resistant and -susceptible parasite isolates." | 7.71 | Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo. ( Coles, GC; Dai, JR; Doenhoff, MJ; Liang, YS; Zhu, YC, 2002) |
"Bithionol was effective and cured the patient." | 5.28 | [Hepatic fascioliasis. Resistance to praziquantel treatment and the radiological findings]. ( Agud, JL; De Juana, P; Gea, F; Mora, P; Rábago, L; Vargas, E, 1992) |
" The introduction of oxamniquine and praziquantel constitutes a break through in the treatment of intestinal and urogenital schistosomiasis." | 4.76 | [Present status of the treatment of helminthiasis]. ( Coulaud, JP, 1984) |
"Repeated praziquantel treatment for schistosomiasis is an effective method to reduce disease burden." | 3.96 | Change in schistosomiasis-related liver disease with repeated praziquantel treatment in school children in rural Zambia. ( McAdam, D; Paul, E; Strahan, R, 2020) |
"After praziquantel treatment for schistosomiasis, parasitological cure rates of 60%-90% are usual." | 3.79 | Sonographic response in the liver and urinary bladder of children 14 months after treatment for schistosomiasis. ( McAdam, D; Schneider, ME; Strahan, R, 2013) |
"To investigate trends in the efficacy of praziquantel (PZQ) suggestive of the emergence of drug resistance against Schistosoma mansoni infection after 12." | 3.75 | Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya. ( Black, CL; Colley, DG; Evan Secor, W; Karanja, DM; Mwinzi, PN; Steinauer, ML, 2009) |
"The effect of treatment with praziquantel (PZQ) on the tegument of adult Schistosoma mansoni worms and on liver egg-granulomas has been examined in mice infected with PZQ-resistant and -susceptible parasite isolates." | 3.71 | Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo. ( Coles, GC; Dai, JR; Doenhoff, MJ; Liang, YS; Zhu, YC, 2002) |
"The effects of different doses of Interferon alpha 2b (IFN alpha 2b), alone and in combination with praziquantel (PZQ), on hepatic schistosomiasis were tested." | 3.70 | Parasitological, pathological and functional studies on the effects of IFN alpha 2b in murine hepatic schistosomiasis. ( Baddour, NM; Eissa, MM, 2000) |
"The purpose of this study was to examine in vivo the activity of cytochrome P450 (CYP) 2A6, an enzyme capable of activating carcinogens, including N-nitrosodimethylamine, in humans with the carcinogenic liver fluke infection, opisthorchiasis viverrini, before and after treatment with the antiparasitic agent, praziquantel." | 3.69 | Induction of cytochrome P450 2A6 expression in humans by the carcinogenic parasite infection, opisthorchiasis viverrini. ( Bartsch, H; Haswell-Elkins, MR; Lang, MA; Mairiang, E; Mairiang, P; Pelkonen, P; Satarug, S; Sithithaworn, P; Yongvanit, P, 1996) |
"41 patients (20 females and 21 males aged from 8 to 68 years) were prescribed 2-cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one(praziquantel, EMBAY 8440, Biltricide) at a dose of 25 mg/kg body weight given three times on a single day at intervals of 4 h, for the treatment of opisthorchiasis." | 3.66 | [Study on the tolerability of high doses of praziquantel in Laotians with parasitic liver infections (author's transl)]. ( Ambroise-Thomas, P; Goullier, A, 1981) |
" Up to now safe and successful treatment of over 25,000 patients has been documented in Africa, Asia and South America with single dose or single day dosage schemes against all five schistosome species pathogenic to man." | 2.65 | The profile of the trematodicidal compound praziquantel. ( Wegner, DH, 1984) |
"He had been previously diagnosed with chronic hepatitis B." | 1.48 | Hepatic Paragonimiasis Mimicking Hepatocellular Carcinoma. ( Fu, YY; Jia, QB; Lin, YX; Xiong, XZ, 2018) |
"Hepatic schistosomiasis is a well recognized cause of chronic liver disease and portal hypertension." | 1.38 | Incidental hepatic schistosomiasis in a liver transplant recipient. ( Ariza-Heredia, E; Razonable, RR, 2012) |
"Its effect on the extent of liver fibrosis, through estimation of hepatic hydroxyproline and hepatic collagen content in liver hydrolysates, was also evaluated." | 1.38 | Tranilast ameliorates impaired hepatic functions in Schistosoma mansoni-infected mice. ( Ammar, EM; Elkashef, WF; Gameil, NM; Said, E; Said, SA, 2012) |
"Clinical hepatomegaly (25 vs." | 1.34 | Liver morbidity due to Schistosoma mekongi in Cambodia after seven rounds of mass drug administration. ( Cheam, S; Degrémont, A; Hatz, C; Keang, H; Odermatt, P; Odermatt-Biays, S, 2007) |
"We report a rare case of intrahepatic cholangiocarcinoma associated with old infestation of Schistosoma japonicum." | 1.34 | Intrahepatic cholangiocarcinoma with old infestation of Schistosoma japonicum: report of a case. ( Aiura, K; Akatsu, T; Kameyama, K; Kawachi, S; Kitagawa, Y; Kitajima, M; Sakamoto, M; Shimazu, M; Shinoda, M; Tanabe, M; Ueda, M, 2007) |
" The recommended dosage of PZQ is a single 40 mg/kg oral dose, and each of these patients continued to pass viable Schistosoma mansoni eggs despite three successive doses at or above this level." | 1.33 | Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt. ( Amer, N; Bennett, JL; Botros, S; Day, TA; El-Ghannam, M; Sayed, H, 2005) |
"Paragonimiasis is an important re-emerging parasitosis in Japan." | 1.31 | Active hepatic capsulitis caused by Paragonimus westermani infection. ( Kamiyama, T; Nakamura-Uchiyama, F; Nawa, Y; Sasaki, M; Yano, T, 2002) |
"Bithionol was effective and cured the patient." | 1.28 | [Hepatic fascioliasis. Resistance to praziquantel treatment and the radiological findings]. ( Agud, JL; De Juana, P; Gea, F; Mora, P; Rábago, L; Vargas, E, 1992) |
"), each time approximately 5 weeks after dosing with 60-80 OV metacercariae at weeks 0, 8, 16, 24 and 32." | 1.28 | Repeated exposure to Opisthorchis viverrini and treatment with the antihelminthic Praziquantel lacks carcinogenic potential. ( Ito, N; Moore, MA; Ruchirawat, S; Thamavit, W, 1992) |
" Both the peak plasma concentration of praziquantel and the bioavailability (measured as the area under the plasma concentration time curve) were significantly greater in the two groups of patients with liver disease (P less than ." | 1.27 | Praziquantel pharmacokinetics and side effects in Schistosoma japonicum-infected patients with liver disease. ( Fernando, MT; Laughlin, LW; Padre, L; Ranoa, CP; Ritter, W; Watt, G; White, NJ, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (23.19) | 18.7374 |
1990's | 19 (27.54) | 18.2507 |
2000's | 22 (31.88) | 29.6817 |
2010's | 11 (15.94) | 24.3611 |
2020's | 1 (1.45) | 2.80 |
Authors | Studies |
---|---|
Strahan, R | 2 |
McAdam, D | 2 |
Paul, E | 1 |
Baekby, M | 1 |
Glerup, H | 1 |
Stribolt, K | 1 |
Tarp, B | 1 |
Lin, YX | 1 |
Jia, QB | 1 |
Fu, YY | 1 |
Xiong, XZ | 1 |
Okamoto, K | 1 |
Brown, JD | 1 |
Schneider, ME | 1 |
Othman, AA | 1 |
Shoheib, ZS | 1 |
Abdel-Aleem, GA | 1 |
Shareef, MM | 1 |
Black, CL | 1 |
Steinauer, ML | 1 |
Mwinzi, PN | 1 |
Evan Secor, W | 1 |
Karanja, DM | 1 |
Colley, DG | 1 |
Rahoud, SA | 1 |
Mergani, A | 1 |
Khamis, AH | 1 |
Saeed, OK | 1 |
Mohamed-Ali, Q | 1 |
Dessein, AJ | 1 |
Elwali, NE | 1 |
Velebný, S | 2 |
Hrčkova, G | 2 |
Königová, A | 1 |
Lubeya, M | 1 |
Muloshi, C | 1 |
Baboo, KS | 1 |
Sianongo, S | 1 |
Kelly, P | 1 |
Göbel, T | 1 |
Erhardt, A | 1 |
Richter, J | 1 |
Poremba, C | 1 |
Häussinger, D | 1 |
Ariza-Heredia, E | 1 |
Razonable, RR | 1 |
Said, E | 1 |
Said, SA | 1 |
Elkashef, WF | 1 |
Gameil, NM | 1 |
Ammar, EM | 1 |
Park, CW | 1 |
Chung, WJ | 1 |
Kwon, YL | 1 |
Kim, YJ | 1 |
Kim, ES | 1 |
Jang, BK | 1 |
Park, KS | 1 |
Cho, KB | 1 |
Hwang, JS | 1 |
Kwon, JH | 1 |
Sasaki, M | 1 |
Kamiyama, T | 1 |
Yano, T | 1 |
Nakamura-Uchiyama, F | 1 |
Nawa, Y | 1 |
el-Shafei, MM | 1 |
Mattar, MA | 1 |
Afify, HA | 1 |
Takemasa, H | 1 |
Saito, K | 1 |
Nakayamada, S | 1 |
Kanazawa, T | 1 |
Tanaka, Y | 1 |
La Flamme, AC | 1 |
MacDonald, AS | 1 |
Huxtable, CR | 1 |
Carroll, M | 1 |
Pearce, EJ | 1 |
Liang, YS | 1 |
Coles, GC | 1 |
Dai, JR | 1 |
Zhu, YC | 1 |
Doenhoff, MJ | 1 |
Chu, DW | 1 |
Li, JC | 1 |
Lee, DW | 1 |
Rong, ZX | 1 |
Chen, XW | 1 |
Chan, AC | 1 |
Mairiang, E | 2 |
Mairiang, P | 2 |
Jongsuksuntigul, P | 1 |
Imsomboon, T | 1 |
Botros, S | 1 |
Sayed, H | 1 |
Amer, N | 1 |
El-Ghannam, M | 1 |
Bennett, JL | 1 |
Day, TA | 1 |
Chigusa, Y | 1 |
Otake, H | 1 |
Ohmae, H | 2 |
Kirinoki, M | 1 |
Ilagan, EJ | 1 |
Barzaga, NG | 1 |
Kawabata, M | 1 |
Hayashi, M | 2 |
Matsuda, H | 1 |
Hoare, M | 1 |
Gelson, WT | 1 |
Davies, SE | 1 |
Curran, M | 1 |
Alexander, GJ | 1 |
Balbaa, M | 1 |
Bassiouny, K | 1 |
Andrade, ZA | 1 |
Baptista, AP | 1 |
Santana, TS | 1 |
Keang, H | 1 |
Odermatt, P | 1 |
Odermatt-Biays, S | 1 |
Cheam, S | 1 |
Degrémont, A | 1 |
Hatz, C | 1 |
Chai, JY | 1 |
Han, ET | 1 |
Guk, SM | 1 |
Shin, EH | 1 |
Sohn, WM | 1 |
Yong, TS | 1 |
Eom, KS | 1 |
Lee, KH | 1 |
Jeong, HG | 1 |
Ryang, YS | 1 |
Hoang, EH | 1 |
Phommasack, B | 1 |
Insisiengmay, B | 1 |
Lee, SH | 1 |
Rim, HJ | 1 |
Akatsu, T | 1 |
Shimazu, M | 1 |
Shinoda, M | 1 |
Kawachi, S | 1 |
Tanabe, M | 1 |
Aiura, K | 1 |
Ueda, M | 1 |
Kameyama, K | 1 |
Sakamoto, M | 1 |
Kitajima, M | 1 |
Kitagawa, Y | 1 |
Kogan, G | 1 |
Coulaud, JP | 1 |
Wegner, DH | 1 |
Southwood, T | 1 |
Davidson, GP | 1 |
Phillips, GE | 1 |
Rice, M | 1 |
Coutinho, A | 1 |
Domingues, AL | 1 |
Neves, J | 1 |
Almeida, ST | 1 |
Ziegler, K | 1 |
Moeller, FW | 1 |
Lafrenz, M | 1 |
Ambroise-Thomas, P | 2 |
Goullier, A | 2 |
da Silva, LC | 1 |
Sette, H | 1 |
Christo, CH | 1 |
Sáez-Alquezar, A | 1 |
Carneiro, CR | 1 |
Lacet, CM | 1 |
Ohtsuki, N | 1 |
Raia, S | 1 |
Bonnet-Eymard, J | 1 |
Fournet, J | 1 |
Sickel, JZ | 1 |
Fultz, PJ | 1 |
Penwarden, B | 1 |
Laczin, J | 1 |
Green, LE | 1 |
Berriatua, E | 1 |
Morgan, KL | 1 |
Wirth, HP | 1 |
Casanova, C | 1 |
Meyenberger, C | 1 |
Hammer, B | 1 |
Ammann, R | 1 |
Blum, HE | 1 |
Fukunaga, K | 1 |
Nozue, M | 1 |
Moon, Y | 1 |
Monoi, H | 1 |
Yamamoto, Y | 1 |
Osada, A | 1 |
Kawamoto, T | 1 |
Koike, N | 1 |
Fukao, K | 1 |
Kawashima, T | 4 |
Sekiya, C | 4 |
Satarug, S | 1 |
Lang, MA | 1 |
Yongvanit, P | 1 |
Sithithaworn, P | 1 |
Pelkonen, P | 1 |
Bartsch, H | 1 |
Haswell-Elkins, MR | 1 |
Badawy, AA | 1 |
el-Badrawy, NM | 1 |
Mansy, SS | 2 |
Akl, MM | 1 |
Abdel Hady, AM | 1 |
Ebeid, FA | 1 |
Hassan, MM | 2 |
Queneau, PE | 1 |
Koch, S | 1 |
Bresson-Hadni, S | 1 |
Bartholomot, B | 1 |
Arbez-Gindre, F | 1 |
Heyd, B | 1 |
Miguet, JP | 1 |
Yehia, HA | 1 |
Hassan, EA | 1 |
Youssef, MM | 1 |
Hadi, AA | 1 |
Mackenzie, CD | 1 |
Ohnishi, K | 1 |
Kohgo, Y | 1 |
Mola, PW | 1 |
Farah, IO | 2 |
Kariuki, TM | 1 |
Nyindo, M | 1 |
Blanton, RE | 1 |
King, CL | 1 |
Johansson, M | 1 |
Lövgren-Bengtson, K | 1 |
Hau, J | 1 |
Hwang, YJ | 1 |
Kim, YI | 1 |
Yun, YK | 1 |
Kim, JW | 1 |
Eissa, MM | 1 |
Baddour, NM | 1 |
Mora, P | 1 |
Gea, F | 1 |
Agud, JL | 1 |
Rábago, L | 1 |
Vargas, E | 1 |
De Juana, P | 1 |
Tanaka, M | 1 |
Matsuzaki, Y | 1 |
Kurosaki, Y | 1 |
Blas, BL | 1 |
Portillo, GG | 1 |
Sy, OS | 1 |
Irie, Y | 1 |
Yasuraoka, K | 1 |
Khayyal, MT | 2 |
Saleh, S | 1 |
Metwally, AA | 2 |
Botros, SS | 2 |
Mahmoud, MR | 1 |
Thamavit, W | 1 |
Moore, MA | 1 |
Ruchirawat, S | 1 |
Ito, N | 1 |
Zwingenberger, K | 2 |
Irschick, E | 1 |
Vergetti Siqueira, JG | 1 |
Correia Dacal, AR | 1 |
Feldmeier, H | 2 |
Kassirer, JP | 1 |
Kopelman, RI | 1 |
Harms, G | 1 |
Müller, O | 1 |
Steiner, A | 1 |
Bienzle, U | 1 |
el-Badrawy, N | 1 |
Watt, G | 1 |
White, NJ | 1 |
Padre, L | 1 |
Ritter, W | 1 |
Fernando, MT | 1 |
Ranoa, CP | 1 |
Laughlin, LW | 1 |
Mongkolintra, S | 1 |
Leelapanmetha, P | 1 |
Sornmani, S | 1 |
Fungladda, W | 1 |
Siripornpitak, S | 1 |
Siriwichai, P | 1 |
Chauyna, N | 1 |
Srithip, U | 1 |
Impand, P | 1 |
Mahatuirunkul, S | 1 |
Massoud, AM | 1 |
Ghoneem, M | 1 |
Massoud, M | 1 |
el-Rooby, A | 1 |
Rainsford, KD | 1 |
10 reviews available for praziquantel and Liver Diseases, Parasitic
Article | Year |
---|---|
Clinical manifestation of opisthorchiasis and treatment.
Topics: Animals; Anthelmintics; Biliary Tract Diseases; Cholangiocarcinoma; Female; Humans; Liver Diseases, | 2003 |
Opisthorchiasis control in Thailand.
Topics: Animals; Anthelmintics; Food Parasitology; Health Education; Humans; Liver Diseases, Parasitic; Opis | 2003 |
[Present status of the treatment of helminthiasis].
Topics: Albendazole; Anthelmintics; Benzimidazoles; Cestode Infections; Echinococcosis; Helminthiasis; Human | 1984 |
[Hepatosplenic schistosomiasis: case report and clinical review].
Topics: Adult; Animals; Feces; Female; Hepatitis C; Humans; Infant, Newborn; Liver Diseases, Parasitic; Live | 1993 |
[Clonorchiasis].
Topics: Animals; Antiplatyhelmintic Agents; Clonorchiasis; Clonorchis sinensis; Humans; Liver Diseases, Para | 1995 |
[Schistosomiasis japonica of the liver].
Topics: Animals; Antiplatyhelmintic Agents; Humans; Liver Diseases, Parasitic; Praziquantel; Schistosoma jap | 1995 |
[Schistosoma haematobium].
Topics: Animals; Antiplatyhelmintic Agents; Diagnosis, Differential; Humans; Liver Diseases, Parasitic; Praz | 1995 |
[Schistosomiasis (intestinal, hepatic, urinary tract)].
Topics: Diagnosis, Differential; Humans; Intestinal Diseases, Parasitic; Liver Diseases, Parasitic; Praziqua | 1999 |
[Clonorchiasis].
Topics: Animals; Clonorchiasis; Clonorchis sinensis; Diagnosis, Differential; Host-Parasite Interactions; Hu | 1999 |
Management of hepatic schistosomiasis.
Topics: Acute Disease; Animals; Central Nervous System; Child; Chronic Disease; Colon; Diagnosis, Differenti | 1985 |
1 trial available for praziquantel and Liver Diseases, Parasitic
Article | Year |
---|---|
The profile of the trematodicidal compound praziquantel.
Topics: Clinical Trials as Topic; Echinococcosis; Humans; Isoquinolines; Kinetics; Liver Diseases, Parasitic | 1984 |
58 other studies available for praziquantel and Liver Diseases, Parasitic
Article | Year |
---|---|
Change in schistosomiasis-related liver disease with repeated praziquantel treatment in school children in rural Zambia.
Topics: Adolescent; Animals; Anthelmintics; Child; Child, Preschool; Female; Humans; Liver Diseases, Parasit | 2020 |
Hepatosplenic schistosomiasis: playing hide-and-seek with an elusive parasite.
Topics: Abdominal Pain; Adult; Animals; Denmark; Eritrea; Humans; Liver Diseases, Parasitic; Male; Praziquan | 2017 |
Hepatic Paragonimiasis Mimicking Hepatocellular Carcinoma.
Topics: Adult; Animals; Anthelmintics; Carcinoma, Hepatocellular; Diagnosis, Differential; Hepatectomy; Hepa | 2018 |
Hepatosplenic schistosomiasis presenting as spontaneous hemoperitoneum in a Filipino immigrant.
Topics: Adult; Animals; Female; Hawaii; Hemoperitoneum; Humans; Liver Diseases, Parasitic; Philippines; Praz | 2013 |
Sonographic response in the liver and urinary bladder of children 14 months after treatment for schistosomiasis.
Topics: Adolescent; Anthelmintics; Child; Child, Preschool; Humans; Liver; Liver Diseases, Parasitic; Praziq | 2013 |
Experimental schistosomal hepatitis: protective effect of coenzyme-Q10 against the state of oxidative stress.
Topics: Actins; Animals; Anthelmintics; Aryldialkylphosphatase; Biomphalaria; Carboxylic Ester Hydrolases; D | 2008 |
Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya.
Topics: Adult; Animals; Anthelmintics; Drug Resistance; HIV Infections; Humans; Liver Diseases, Parasitic; L | 2009 |
Factors controlling the effect of praziquantel on liver fibrosis in Schistosoma mansoni-infected patients.
Topics: Adolescent; Adult; Age Factors; Animals; Anthelmintics; Child; Child, Preschool; Disease Progression | 2010 |
Reduction of oxidative stress and liver injury following silymarin and praziquantel treatment in mice with Mesocestoides vogae (Cestoda) infection.
Topics: Animals; Anthelmintics; Antioxidants; Cell Proliferation; Cestode Infections; Drug Therapy, Combinat | 2010 |
Hepatosplenic schistosomiasis.
Topics: Adult; Anthelmintics; Hematemesis; Humans; Liver Diseases, Parasitic; Praziquantel; Schistosomiasis | 2010 |
[Chronic hepatitis B with an unexpected coinfection].
Topics: Adult; Animals; Antiviral Agents; Biopsy; Comorbidity; Drug Administration Schedule; Drug Therapy, C | 2010 |
Incidental hepatic schistosomiasis in a liver transplant recipient.
Topics: Animals; Anthelmintics; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Liver Diseases, Parasi | 2012 |
Tranilast ameliorates impaired hepatic functions in Schistosoma mansoni-infected mice.
Topics: Animals; Anthelmintics; Disease Models, Animal; Drug Therapy, Combination; Liver Cirrhosis; Liver Di | 2012 |
Consecutive extrapulmonary paragonimiasis involving liver and colon.
Topics: Adult; Animals; Anthelmintics; Colon; Colonic Diseases; Eosinophilia; Female; Humans; Intestinal Dis | 2012 |
Active hepatic capsulitis caused by Paragonimus westermani infection.
Topics: Adult; Animals; Anthelmintics; Antibodies, Helminth; Antigens, Helminth; Humans; Liver Abscess; Live | 2002 |
Parasitological and immunological changes in murine hepatic schistosomiasis before and after praziquantel treatment.
Topics: Animals; Anthelmintics; Feces; Hydroxyproline; Intestines; Liver; Liver Diseases, Parasitic; Mice; P | 2002 |
[A case of Paragonimiasis westermanii complicated with migrating subcutaneous induration and multiple involvements in the liver].
Topics: Adult; Anthelmintics; Female; Humans; Larva Migrans; Liver Diseases, Parasitic; Paragonimiasis; Praz | 2002 |
Lack of C3 affects Th2 response development and the sequelae of chemotherapy in schistosomiasis.
Topics: Animals; Anthelmintics; Antigens, Helminth; Cells, Cultured; Complement C3; Cytokines; Immune Tolera | 2003 |
Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
Topics: Animals; Anthelmintics; Drug Resistance; Female; Granuloma; Liver Diseases, Parasitic; Male; Mice; M | 2002 |
Unusual presentations of hepatic clonorchiasis.
Topics: Adult; Anthelmintics; Cholangiopancreatography, Endoscopic Retrograde; Clonorchiasis; Drainage; Huma | 2003 |
Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt.
Topics: Adult; Animals; Anthelmintics; Drug Resistance; Egypt; Female; Humans; Liver Diseases, Parasitic; Ma | 2005 |
Determination of the period for establishment of a liver network echogenic pattern in Schistosoma japonicum infection.
Topics: Animals; Anthelmintics; Child; Enzyme-Linked Immunosorbent Assay; Feces; Female; Humans; Liver; Live | 2006 |
Hepatic and intestinal schistosomiasis after orthotopic liver transplant.
Topics: Animals; Anthelmintics; Antibodies, Helminth; Biopsy; Diagnosis, Differential; Follow-Up Studies; Hu | 2005 |
In vitro effect of schistosomicidal drugs on hepatic arylsulfatase B from the schistosoma-infected mouse.
Topics: Animals; Anthelmintics; Catalysis; Commiphora; Immunization; Immunoprecipitation; In Vitro Technique | 2006 |
Remodeling of hepatic vascular changes after specific chemotherapy of schistosomal periportal fibrosis.
Topics: Animals; Anthelmintics; Chronic Disease; Disease Models, Animal; Female; Granuloma; Humans; Liver Ci | 2006 |
Liver morbidity due to Schistosoma mekongi in Cambodia after seven rounds of mass drug administration.
Topics: Adolescent; Adult; Aged; Animals; Cambodia; Cross-Sectional Studies; Female; Hepatomegaly; Humans; L | 2007 |
High prevalence of liver and intestinal fluke infections among residents of Savannakhet Province in Laos.
Topics: Adolescent; Adult; Aged; Animals; Anthelmintics; Child; Child, Preschool; Feces; Female; Humans; Int | 2007 |
Intrahepatic cholangiocarcinoma with old infestation of Schistosoma japonicum: report of a case.
Topics: Aged; Animals; Antiparasitic Agents; Cholangiocarcinoma; Humans; Liver Diseases, Parasitic; Male; Pr | 2007 |
Impact of treatment with praziquantel, silymarin and/or beta-glucan on pathophysiological markers of liver damage and fibrosis in mice infected with Mesocestoides vogae (Cestoda) tetrathyridia.
Topics: Alanine Transaminase; Animals; Anthelmintics; Antioxidants; Aspartate Aminotransferases; beta-Glucan | 2008 |
Hepatosplenic schistosomiasis in a South-East Asian refugee child in South Australia.
Topics: Australia; Child; Humans; Laos; Liver Diseases, Parasitic; Male; Praziquantel; Refugees; Schistosomi | 1983 |
Treatment of hepatosplenic Schistosomiasis mansoni with praziquantel. Preliminary report on tolerance and efficacy.
Topics: Adolescent; Adult; Child; Electrocardiography; Electroencephalography; Female; Humans; Isoquinolines | 1983 |
Praziquantel compared to hexachloroparaxylol in the treatment of far eastern liver fluke infestation of man.
Topics: Adolescent; Adult; Antiplatyhelmintic Agents; Female; Humans; Isoquinolines; Laos; Liver Diseases, P | 1982 |
[Study on the tolerability of high doses of praziquantel in Laotians with parasitic liver infections (author's transl)].
Topics: Adolescent; Adult; Aged; Child; Humans; Isoquinolines; Laos; Liver Diseases, Parasitic; Male; Middle | 1981 |
Praziquantel in the treatment of the hepatosplenic form of Schistosomiasis mansoni.
Topics: Adolescent; Adult; Child; Electrocardiography; Electroencephalography; Humans; Isoquinolines; Liver | 1981 |
[Treatment of severe Oriental hepatic distomiasis with praziquantel. Preliminary results in 30 patients].
Topics: Isoquinolines; Liver Diseases, Parasitic; Opisthorchiasis; Praziquantel | 1981 |
Hepatic cysticercosis. Report of an unusual case.
Topics: Adenocarcinoma; Biopsy; Colonic Neoplasms; Cysticercosis; Humans; Liver; Liver Diseases, Parasitic; | 1995 |
Prevalence, possible aetiologies, control and cost of parasitic lesions in three flocks of housed lambs.
Topics: Animal Husbandry; Animals; Cysticercosis; Dog Diseases; Dogs; Liver Diseases, Parasitic; Praziquante | 1994 |
[Cholangiocarcinoma at the hepatic hilus with clonorchiasis].
Topics: Adenoma, Bile Duct; Bile Duct Neoplasms; Clonorchiasis; Female; Humans; Liver Diseases, Parasitic; M | 1993 |
Induction of cytochrome P450 2A6 expression in humans by the carcinogenic parasite infection, opisthorchiasis viverrini.
Topics: Analysis of Variance; Animals; Antiplatyhelmintic Agents; Aryl Hydrocarbon Hydroxylases; Bile Ducts, | 1996 |
Evaluation of colchicine with or without praziquantel therapy in the control of hepatic fibrosis in murine schistosomiasis.
Topics: Animals; Body Weight; Colchicine; Collagen; Connective Tissue; Female; Liver Cirrhosis, Experimental | 1996 |
[Pseudotumor form of hepatic distomatosis: successful treatment with praziquantel].
Topics: Antiplatyhelmintic Agents; Diagnosis, Differential; Fascioliasis; Female; Humans; Liver Diseases, Pa | 1997 |
Octreotide decreases connective tissue formation and improves vascular changes associated with hepatic schistosomiasis.
Topics: Animals; Drug Therapy, Combination; Egypt; Female; Liver Cirrhosis; Liver Diseases, Parasitic; Mice; | 1998 |
Cytokine control of the granulomatous response in Schistosoma mansoni-infected baboons: role of exposure and treatment.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Cytokines; Disease Models, Animal; Feces; Granulo | 1999 |
Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Cells, Cultured; Concanavalin A; Culture Media; C | 2000 |
Use of liver graft infested with Clonorchis sinensis for living related liver transplantation: a case report.
Topics: Adult; Animals; Anthelmintics; Clonorchiasis; Clonorchis sinensis; Fathers; Hepatectomy; Humans; Inf | 2000 |
Parasitological, pathological and functional studies on the effects of IFN alpha 2b in murine hepatic schistosomiasis.
Topics: Animals; Anthelmintics; Drug Therapy, Combination; Interferon alpha-2; Interferon-alpha; Liver Disea | 2000 |
[Hepatic fascioliasis. Resistance to praziquantel treatment and the radiological findings].
Topics: Aged; Bithionol; Drug Resistance; Fascioliasis; Humans; Liver; Liver Diseases, Parasitic; Male; Praz | 1992 |
Improvement of ultrasonographic and serologic changes in Schistosoma japonicum-infected patients after treatment with praziquantel.
Topics: Adolescent; Adult; Bile Acids and Salts; Female; Humans; Hypertension, Portal; Liver Diseases, Paras | 1992 |
Schistosoma mansoni: angiotensin converting enzyme activity in mice under the influence of praziquantel and/or captopril.
Topics: Animals; Captopril; Drug Therapy, Combination; Granuloma; Intestines; Liver; Liver Diseases, Parasit | 1991 |
Repeated exposure to Opisthorchis viverrini and treatment with the antihelminthic Praziquantel lacks carcinogenic potential.
Topics: Animals; Body Weight; Cricetinae; Liver Diseases, Parasitic; Liver Neoplasms, Experimental; Male; Me | 1992 |
Tumour necrosis factor in hepatosplenic schistosomiasis.
Topics: Adolescent; Adult; Aged; Biopterins; Cells, Cultured; Child; Female; Humans; Interleukin-1; Leukocyt | 1990 |
A diagnostic fluke.
Topics: Animals; Aorta, Abdominal; Aortic Aneurysm; Biopsy, Needle; Diagnostic Errors; Fatty Liver; Humans; | 1989 |
Liver involvement in human schistosomiasis mansoni. Regression of immunological and biochemical disease markers after specific treatment.
Topics: Adolescent; Adult; Animals; Antibodies, Helminth; beta 2-Microglobulin; Biopterins; Child; Child, Pr | 1988 |
Study of some immunopharmacological properties of praziquantel in experimental schistosomiasis mansoni.
Topics: Animals; Antigen-Antibody Reactions; Fluorescent Antibody Technique; Granuloma; Hypersensitivity, De | 1986 |
Praziquantel pharmacokinetics and side effects in Schistosoma japonicum-infected patients with liver disease.
Topics: Biological Availability; Female; Humans; Liver Diseases, Parasitic; Male; Praziquantel; Schistosomia | 1988 |
Encouraging self-reliance in the fight against liver fluke.
Topics: Animals; Humans; Liver Diseases, Parasitic; Opisthorchidae; Pilot Projects; Praziquantel; Thailand; | 1988 |
Effect of oxamniquine and praziquantel on intrasplenic pressure and portal vein diameter in hepatosplenic schistosomiasis.
Topics: Adult; Blood Pressure; Humans; Liver Diseases, Parasitic; Male; Nitroquinolines; Oxamniquine; Portal | 1986 |
Pharmacological manipulation of the chronic granulomatous reactions in the livers of mice infected with schistosomiasis.
Topics: Animals; Granuloma; Indomethacin; Liver Diseases, Parasitic; Mice; Praziquantel; Schistosoma mansoni | 1985 |